Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile.
about
Cytogenetic features in myelodysplastic syndromesProteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.RAD51AP1-deficiency in vertebrate cells impairs DNA replication.XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia.Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeA distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).Allelic imbalances in radiation-associated acute myeloid leukemia.Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics.Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignanciesNoncytotoxic differentiation treatment of renal cell cancer.Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor GrowthSIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.Applications of microarray technology to Acute Myelogenous LeukemiaInteractive diagnostics in the indication to allogeneic SCT in AML.Unfavorable-risk cytogenetics in acute myeloid leukemia.Genome-scale technology driven advances to research into normal and malignant haematopoiesis.Genomic characterization of acute leukemias.DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair.TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes.The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia.Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.Anti-leukaemic effects induced by APR-246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells.Identification of novel cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.Chromothripsis in acute myeloid leukemia: Biological features and impact on survival.Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities.Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.Chromothripsis in acute myeloid leukemia: biological features and impact on survival.A new adult AML case with an extremely complex karyotype, remission and relapse combined with high hyperdiploidy of a normal chromosome set in secondary AMLAcute myeloid leukemiaHyperdiploidy with 49–65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcomeAcute Myeloid Leukemia
P2860
Q24644654-FE985975-E9F0-4093-95D7-7E78962C2057Q33244998-83CC6F28-7A72-44D5-9EFA-A416154776DDQ34624427-F7C4EE7E-40C4-4F4B-8F4E-820602585E53Q34629500-DF951AC7-7DB6-46C9-A5D4-5D20CF36401BQ35249211-DECE2211-0C58-4E16-89A6-DBB6A86FB5B1Q35921510-F196E8FC-25E2-4BC4-92BE-12803292B75EQ36064278-8843D15F-1EDE-4D0B-80D9-331E67722989Q36180049-F93EF031-A2C5-4CE7-8142-1663CDF71C55Q36579076-E8DAE5B6-02BF-414C-9D9A-9EF0C4CEDAD6Q36808186-A09C1E62-5EC6-4F23-932C-AF824E35A08BQ36848202-29179653-5E04-49CE-828F-20380870660CQ36866357-3C2568EE-C535-486A-9545-57D76D9812DBQ36963419-1A140400-6DC9-412F-9DE6-00BAAD6A02C7Q36996528-872AF666-8438-4FB6-B2F2-5EE1C0896571Q37437233-50EEB4D3-2EA0-425F-BEB8-DF4B47D37089Q37442649-23900283-EA05-45E7-BDC3-7A78F8AE71ACQ37865545-11F3C02F-BDF7-4F2A-9278-30E5CAB7E62FQ38166364-4BEA9BFF-DEE6-4035-9519-C76C6D4503D5Q38223490-444627C1-EBF8-46BF-91C0-5A83993DB225Q38238954-060AF97E-003A-4E89-839B-DA657BFF9F68Q38694866-FB43173E-07DC-42E7-AEEF-62A154B0EC74Q38892311-2C9FA145-4956-4C68-8145-F22CCE9466D4Q39554542-0EF2A2C1-F093-4CEB-9C1A-48F2F625F860Q39555179-7705B0AE-50E8-41C2-986E-65B063978620Q40009452-2EEE1768-BF79-4FE6-8D12-9024459DAD2DQ40381532-A7944913-6628-4462-981E-399FE3E882E3Q41508288-F762C819-7916-4C09-9C0B-0867EC210DDDQ46577501-83132ED4-F36A-440C-AB7F-A9E6C6B09E50Q47416249-994D66F3-C078-4F89-B678-E59F6B8B7705Q47574634-20D8A31E-8361-4AEA-BAB9-C9E885F5FBBEQ48252205-2B66B655-5974-45C6-B50B-7FD0589DECE6Q52347275-D3B52B21-10DA-4AF4-A42D-220811F1C3FEQ52374501-453F3E6A-C6A1-47B4-B715-14A4CFEE1C64Q56517348-3F52D46D-38AC-489C-8185-DA9F30430DC2Q58481761-76CAA753-C787-42E7-B494-DE75B5EC4C0CQ58481777-19B07410-E029-4A86-A2F4-B975944A151DQ58481811-74D718E7-09DE-4871-A11C-1D1115FB1BEC
P2860
Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Acute myeloid leukemia with a ...... cific gene expression profile.
@ast
Acute myeloid leukemia with a ...... cific gene expression profile.
@en
type
label
Acute myeloid leukemia with a ...... cific gene expression profile.
@ast
Acute myeloid leukemia with a ...... cific gene expression profile.
@en
prefLabel
Acute myeloid leukemia with a ...... cific gene expression profile.
@ast
Acute myeloid leukemia with a ...... cific gene expression profile.
@en
P2093
P50
P356
P1476
Acute myeloid leukemia with a ...... cific gene expression profile.
@en
P2093
Alexander Kohlmann
Wolfgang Hiddemann
Wolfgang Kern
P304
P356
10.1002/GCC.20193
P577
2005-07-01T00:00:00Z